Shaan Syed Khurshid, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 26 | 2023 | 4562 | 3.370 |
Why?
|
Cardiomyopathies | 7 | 2023 | 1832 | 1.720 |
Why?
|
Electrocardiography | 10 | 2023 | 6387 | 1.530 |
Why?
|
Stroke | 12 | 2022 | 9504 | 1.160 |
Why?
|
Brugada Syndrome | 1 | 2021 | 101 | 0.770 |
Why?
|
Atrial Flutter | 1 | 2022 | 252 | 0.750 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 1002 | 0.730 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 594 | 0.700 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2021 | 1994 | 0.680 |
Why?
|
Electric Countershock | 1 | 2021 | 515 | 0.670 |
Why?
|
Perceptual Disorders | 2 | 2011 | 195 | 0.670 |
Why?
|
Heart Ventricles | 4 | 2022 | 3800 | 0.660 |
Why?
|
Cryosurgery | 1 | 2022 | 413 | 0.650 |
Why?
|
Arrhythmias, Cardiac | 2 | 2018 | 2145 | 0.630 |
Why?
|
Cardiac Pacing, Artificial | 2 | 2021 | 844 | 0.600 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2017 | 122 | 0.590 |
Why?
|
Electric Stimulation Therapy | 1 | 2022 | 617 | 0.570 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 840 | 0.560 |
Why?
|
Phenethylamines | 1 | 2015 | 104 | 0.530 |
Why?
|
Risk Assessment | 11 | 2022 | 23482 | 0.520 |
Why?
|
Heart Conduction System | 2 | 2018 | 1029 | 0.510 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1405 | 0.500 |
Why?
|
Ventricular Function, Right | 2 | 2022 | 577 | 0.480 |
Why?
|
Ventricular Function, Left | 5 | 2022 | 3357 | 0.450 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 493 | 0.430 |
Why?
|
Incidence | 11 | 2023 | 20761 | 0.410 |
Why?
|
Catheter Ablation | 2 | 2022 | 2559 | 0.410 |
Why?
|
Models, Genetic | 1 | 2021 | 3522 | 0.400 |
Why?
|
Anticoagulants | 4 | 2020 | 4375 | 0.400 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2033 | 0.400 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 764 | 0.390 |
Why?
|
Reperfusion | 1 | 2011 | 291 | 0.370 |
Why?
|
Artificial Intelligence | 1 | 2021 | 1745 | 0.370 |
Why?
|
Pacemaker, Artificial | 1 | 2014 | 767 | 0.350 |
Why?
|
Vision, Monocular | 1 | 2009 | 72 | 0.350 |
Why?
|
Bradycardia | 2 | 2022 | 285 | 0.350 |
Why?
|
Mass Screening | 3 | 2022 | 5219 | 0.340 |
Why?
|
Risk Factors | 15 | 2023 | 70931 | 0.300 |
Why?
|
Brain Ischemia | 1 | 2020 | 3312 | 0.280 |
Why?
|
Middle Aged | 26 | 2022 | 214639 | 0.280 |
Why?
|
Sulfonamides | 1 | 2015 | 1923 | 0.270 |
Why?
|
Humans | 44 | 2023 | 715594 | 0.240 |
Why?
|
Predictive Value of Tests | 6 | 2023 | 15185 | 0.240 |
Why?
|
Aged | 22 | 2022 | 162392 | 0.240 |
Why?
|
Stroke Volume | 4 | 2022 | 4482 | 0.240 |
Why?
|
Male | 28 | 2022 | 350143 | 0.230 |
Why?
|
Electronic Health Records | 4 | 2022 | 4276 | 0.220 |
Why?
|
Heart Failure | 5 | 2022 | 10041 | 0.220 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1345 | 0.210 |
Why?
|
Aged, 80 and over | 12 | 2022 | 58293 | 0.210 |
Why?
|
Female | 26 | 2022 | 377052 | 0.210 |
Why?
|
Time Factors | 6 | 2021 | 40889 | 0.210 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 665 | 0.200 |
Why?
|
Endophenotypes | 1 | 2022 | 245 | 0.200 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5269 | 0.190 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2740 | 0.190 |
Why?
|
Algorithms | 3 | 2020 | 13761 | 0.190 |
Why?
|
Action Potentials | 2 | 2018 | 1781 | 0.190 |
Why?
|
Age Factors | 4 | 2021 | 18772 | 0.180 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 810 | 0.180 |
Why?
|
Tricuspid Valve | 1 | 2022 | 394 | 0.180 |
Why?
|
Survival Rate | 4 | 2021 | 13209 | 0.170 |
Why?
|
Genome-Wide Association Study | 5 | 2023 | 11956 | 0.170 |
Why?
|
Prevalence | 3 | 2023 | 14877 | 0.170 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 568 | 0.170 |
Why?
|
Attention | 1 | 2009 | 2384 | 0.170 |
Why?
|
Long QT Syndrome | 1 | 2022 | 421 | 0.170 |
Why?
|
Retrospective Studies | 9 | 2022 | 72448 | 0.160 |
Why?
|
Electronic Prescribing | 1 | 2018 | 120 | 0.160 |
Why?
|
Models, Economic | 1 | 2021 | 719 | 0.150 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39334 | 0.150 |
Why?
|
Cardiovascular System | 1 | 2023 | 763 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 940 | 0.150 |
Why?
|
Health Services Misuse | 1 | 2018 | 242 | 0.140 |
Why?
|
Heart Rate | 2 | 2018 | 4090 | 0.140 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 689 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 646 | 0.140 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 34 | 0.140 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 829 | 0.140 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1043 | 0.140 |
Why?
|
Echocardiography | 3 | 2022 | 5045 | 0.140 |
Why?
|
Treatment Outcome | 5 | 2021 | 62039 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1627 | 0.130 |
Why?
|
Natural Language Processing | 1 | 2022 | 954 | 0.130 |
Why?
|
Cognition Disorders | 1 | 2009 | 3974 | 0.130 |
Why?
|
Fever | 1 | 2022 | 1586 | 0.130 |
Why?
|
Aorta | 1 | 2022 | 2071 | 0.130 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1239 | 0.130 |
Why?
|
Prospective Studies | 4 | 2021 | 51354 | 0.120 |
Why?
|
Administration, Oral | 2 | 2018 | 3951 | 0.110 |
Why?
|
Pennsylvania | 1 | 2014 | 655 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 535 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3686 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12495 | 0.110 |
Why?
|
Primary Health Care | 3 | 2023 | 4523 | 0.110 |
Why?
|
Equipment Failure | 1 | 2014 | 580 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12490 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2720 | 0.100 |
Why?
|
Recovery of Function | 1 | 2021 | 2920 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3278 | 0.100 |
Why?
|
Recurrence | 3 | 2020 | 8238 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3543 | 0.090 |
Why?
|
Eye Protective Devices | 1 | 2009 | 32 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2752 | 0.090 |
Why?
|
Spatial Behavior | 1 | 2009 | 93 | 0.090 |
Why?
|
Sensory Deprivation | 1 | 2009 | 109 | 0.090 |
Why?
|
Health Care Costs | 1 | 2021 | 3165 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3898 | 0.080 |
Why?
|
Orientation | 1 | 2009 | 325 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2326 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 14439 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2022 | 3159 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 6868 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1215 | 0.080 |
Why?
|
Life Style | 1 | 2018 | 3747 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4272 | 0.070 |
Why?
|
Space Perception | 1 | 2009 | 471 | 0.070 |
Why?
|
Exercise | 1 | 2021 | 5428 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15900 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 11192 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8996 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8742 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2011 | 2014 | 0.060 |
Why?
|
Brain | 1 | 2011 | 25189 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 7015 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10429 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9977 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6284 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7445 | 0.060 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 82 | 0.060 |
Why?
|
Adult | 6 | 2022 | 212237 | 0.060 |
Why?
|
Body Weights and Measures | 1 | 2022 | 216 | 0.060 |
Why?
|
Visual Fields | 1 | 2009 | 1027 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1334 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2288 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 173 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 9744 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13605 | 0.050 |
Why?
|
Cohort Studies | 3 | 2022 | 40040 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1937 | 0.050 |
Why?
|
United States | 4 | 2021 | 67895 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9028 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 23385 | 0.050 |
Why?
|
Heart | 2 | 2023 | 4308 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17399 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1337 | 0.040 |
Why?
|
Automation | 1 | 2020 | 589 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 34429 | 0.040 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 650 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1779 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3312 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 649 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 803 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16302 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 1975 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1603 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 2015 | 236 | 0.030 |
Why?
|
Registries | 2 | 2020 | 8042 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3521 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1608 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1053 | 0.030 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1113 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4689 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13635 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 13215 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 1984 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7901 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10660 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3014 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 6162 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12547 | 0.020 |
Why?
|
Blood Pressure | 1 | 2019 | 8534 | 0.020 |
Why?
|
Quality Improvement | 1 | 2018 | 3738 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8950 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8270 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20337 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 28991 | 0.010 |
Why?
|